- Home
- VRNA vs AVAL Comparison
VRNA vs AVAL Comparison
Compare VRNA & AVAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- AVAL
- Stock Information
- Founded
- VRNA 2005
- AVAL 1994
- Country
- VRNA United Kingdom
- AVAL Colombia
- Employees
- VRNA N/A
- AVAL N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- AVAL Commercial Banks
- Sector
- VRNA Health Care
- AVAL Finance
- Exchange
- VRNA Nasdaq
- AVAL Nasdaq
- Market Cap
- VRNA 3.4B
- AVAL 2.4B
- IPO Year
- VRNA 2017
- AVAL N/A
- Fundamental
- Price
- VRNA $48.33
- AVAL $2.10
- Analyst Decision
- VRNA Strong Buy
- AVAL
- Analyst Count
- VRNA 6
- AVAL 0
- Target Price
- VRNA $43.83
- AVAL N/A
- AVG Volume (30 Days)
- VRNA 854.0K
- AVAL 50.7K
- Earning Date
- VRNA 02-27-2025
- AVAL 11-15-2024
- Dividend Yield
- VRNA N/A
- AVAL 5.62%
- EPS Growth
- VRNA N/A
- AVAL 150.80
- EPS
- VRNA N/A
- AVAL 0.01
- Revenue
- VRNA $5,624,000.00
- AVAL $2,745,537,342.00
- Revenue This Year
- VRNA N/A
- AVAL N/A
- Revenue Next Year
- VRNA $644.06
- AVAL $15.37
- P/E Ratio
- VRNA N/A
- AVAL $12.29
- Revenue Growth
- VRNA 1127.95
- AVAL N/A
- 52 Week Low
- VRNA $11.39
- AVAL $1.94
- 52 Week High
- VRNA $47.29
- AVAL $2.71
- Technical
- Relative Strength Index (RSI)
- VRNA 71.27
- AVAL 42.38
- Support Level
- VRNA $45.05
- AVAL $2.00
- Resistance Level
- VRNA $47.29
- AVAL $2.10
- Average True Range (ATR)
- VRNA 2.21
- AVAL 0.05
- MACD
- VRNA 0.45
- AVAL -0.01
- Stochastic Oscillator
- VRNA 100.00
- AVAL 30.00
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About AVAL Grupo Aval Acciones y Valores S.A. ADR (Each representing 20 preferred shares)
Grupo Aval Acciones y Valores SA is a Colombian financial services company. Its local operations consist of commercial banking (Banco de Bogota, Banco de Occidente, Banco Popular, and Banco AV Villas), pension fund management (Porvenir), and merchant banking (Corficolombiana). Outside Colombia, the company offers (via BAC Credomatic operations) consumer and credit card banking businesses in Central American countries (Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, and Panama) and Mexico. BAC Credomatic has key alliances with major credit card networks, such as Visa, MasterCard, American Express, and Diners Club.